Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Helicopter crashes during power line work, killing two on board and prompting river closure as investigation begins.
Decades after 9/11, advanced DNA testing identifies three more victims, providing closure to families and highlighting the role of science in honoring the tragedy's victims.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Helicopter crashes during power line work, killing two on board and prompting river closure as investigation begins.
Decades after 9/11, advanced DNA testing identifies three more victims, providing closure to families and highlighting the role of science in honoring the tragedy's victims.